On April 27, 2023, Matt Wetzel, Life Sciences Partner at Goodwin, will lead a webinar to address the latest updates on the Inflation Reduction Act and the law’s sweeping changes to how the government intends to pay for pharmaceuticals and biologics. The new Medicare price negotiation program, inflation-based rebates, and other changes to how
More Posts
CMS Issues Guidance and Solicits Comment on the 2026 Inflation Reduction Act Part D Negotiation Process
Goodwin to Host a Conversation on March 1 with Rare Disease Community Leaders
Now Available! Updated Goodwin’s Guide to Biosimilars Litigation and Regulation in the U.S., 2022-2023
Subscribe: Subscribe via RSS
Blogs
Firm/Org